These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1424418)

  • 1. Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction.
    Hebert MF; Roberts JP; Prueksaritanont T; Benet LZ
    Clin Pharmacol Ther; 1992 Nov; 52(5):453-7. PubMed ID: 1424418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine.
    Gomez DY; Wacher VJ; Tomlanovich SJ; Hebert MF; Benet LZ
    Clin Pharmacol Ther; 1995 Jul; 58(1):15-9. PubMed ID: 7628178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin.
    Fromm MF; Busse D; Kroemer HK; Eichelbaum M
    Hepatology; 1996 Oct; 24(4):796-801. PubMed ID: 8855178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity.
    Gorski JC; Vannaprasaht S; Hamman MA; Ambrosius WT; Bruce MA; Haehner-Daniels B; Hall SD
    Clin Pharmacol Ther; 2003 Sep; 74(3):275-87. PubMed ID: 12966371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of rifampin on tacrolimus pharmacokinetics in healthy volunteers.
    Hebert MF; Fisher RM; Marsh CL; Dressler D; Bekersky I
    J Clin Pharmacol; 1999 Jan; 39(1):91-6. PubMed ID: 9987705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of absorption and first-pass gut and hepatic metabolism in humans: studies with cyclosporine.
    Wu CY; Benet LZ; Hebert MF; Gupta SK; Rowland M; Gomez DY; Wacher VJ
    Clin Pharmacol Ther; 1995 Nov; 58(5):492-7. PubMed ID: 7586942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nifedipine-rifampin interaction. Evidence for induction of gut wall metabolism.
    Holtbecker N; Fromm MF; Kroemer HK; Ohnhaus EE; Heidemann H
    Drug Metab Dispos; 1996 Oct; 24(10):1121-3. PubMed ID: 8894514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of food on the pharmacokinetics of cyclosporine in healthy subjects following oral and intravenous administration.
    Gupta SK; Manfro RC; Tomlanovich SJ; Gambertoglio JG; Garovoy MR; Benet LZ
    J Clin Pharmacol; 1990 Jul; 30(7):643-53. PubMed ID: 2391396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of orally and intravenously administered cyclosporine in pre-kidney transplant patients.
    Aweeka FT; Tomlanovich SJ; Prueksaritanont T; Gupta SK; Benet LZ
    J Clin Pharmacol; 1994 Jan; 34(1):60-7. PubMed ID: 8132853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tamoxifen and toremifene concentrations in plasma are greatly decreased by rifampin.
    Kivistö KT; Villikka K; Nyman L; Anttila M; Neuvonen PJ
    Clin Pharmacol Ther; 1998 Dec; 64(6):648-54. PubMed ID: 9871429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: effect of ketoconazole.
    Tsunoda SM; Velez RL; von Moltke LL; Greenblatt DJ
    Clin Pharmacol Ther; 1999 Nov; 66(5):461-71. PubMed ID: 10579473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme induction in the elderly: effect of rifampin on the pharmacokinetics and pharmacodynamics of propafenone.
    Dilger K; Hofmann U; Klotz U
    Clin Pharmacol Ther; 2000 May; 67(5):512-20. PubMed ID: 10824630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple drug interactions with cyclosporine in a heart transplant patient.
    Zylber-Katz E
    Ann Pharmacother; 1995 Feb; 29(2):127-31. PubMed ID: 7756709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of rifampin on the pharmacokinetics of oral and intravenous ondansetron.
    Villikka K; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 1999 Apr; 65(4):377-81. PubMed ID: 10223773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis.
    Kharasch ED; Walker A; Hoffer C; Sheffels P
    Clin Pharmacol Ther; 2004 Nov; 76(5):452-66. PubMed ID: 15536460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin.
    Gorski JC; Jones DR; Haehner-Daniels BD; Hamman MA; O'Mara EM; Hall SD
    Clin Pharmacol Ther; 1998 Aug; 64(2):133-43. PubMed ID: 9728893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-drug interaction after single oral doses of the furanocoumarin methoxsalen and cyclosporine.
    Rheeders M; Bouwer M; Goosen TC
    J Clin Pharmacol; 2006 Jul; 46(7):768-75. PubMed ID: 16809802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of semisimultaneous midazolam administration for hepatic and intestinal cytochrome P450 3A phenotyping.
    Lee JI; Chaves-Gnecco D; Amico JA; Kroboth PD; Wilson JW; Frye RF
    Clin Pharmacol Ther; 2002 Dec; 72(6):718-28. PubMed ID: 12496753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjects.
    Dresser GK; Schwarz UI; Wilkinson GR; Kim RB
    Clin Pharmacol Ther; 2003 Jan; 73(1):41-50. PubMed ID: 12545142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elucidating rifampin's inducing and inhibiting effects on glyburide pharmacokinetics and blood glucose in healthy volunteers: unmasking the differential effects of enzyme induction and transporter inhibition for a drug and its primary metabolite.
    Zheng HX; Huang Y; Frassetto LA; Benet LZ
    Clin Pharmacol Ther; 2009 Jan; 85(1):78-85. PubMed ID: 18843263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.